Intranasal fentanyl is a feasible, safe, and effective option for managing acute pain episodes in adults with sickle cell ...

Columnist Oluwatosin Adesoye, a doctor, sorts through the difference between sickle cell anemia and sickle cell disease — and ...

The gene-editing therapy OTQ923 normalized brain blood flow in 3 sickle cell disease patients, suggesting it may lower stroke ...

As a result of being a caregiver for her cousin, columnist Sylvia Amuta says she's now more caring, compassionate, and kind ...

The first healthy volunteer has been dosed in a Phase 1 study of Cellarity's novel globin-switching therapy CLY-124 for ...

Part of my coping mechanism after a sickle cell crisis is to forget it ever happened. To address that, this year I started an audio journal during the recovery process as a way to self-assess where I ...

Most people with SCD seem to meet or exceed current level of physical activity recommendations for the general population, a study shows.

BEAM-101, a treatment for sickle cell disease, showed sustained efficacy and safety over one year in the BEACON Phase 1/2 trial.

Columnist Mary Shaniqua shares the benefits of attending the European Hematology Association's 2025 Congress as a sickle cell patient.